P841 A novel candidate pathway for development of in patients atypical serrated lesions with KRAS mutation in ulcerative colitis

MLA

Shin Maeda, et al. “P841 A Novel Candidate Pathway for Development of in Patients Atypical Serrated Lesions with KRAS Mutation in Ulcerative Colitis.” Journal of Crohn’s and Colitis, vol. 12, Jan. 2018, pp. S541–42. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjx180.968.

APA

Shin Maeda, A. Takase, K. Hirasawa, Yu Hashimoto, Y. Inayama, Masafumi Nishio, T Ogashiwa, K. Okawa, W. Shibata, H. Otake, S. Chiba, W. Ueda, Hideaki Kimura, Yoichi Ajioka, & Reiko Kunisaki. (2018). P841 A novel candidate pathway for development of in patients atypical serrated lesions with KRAS mutation in ulcerative colitis. Journal of Crohn’s and Colitis, 12, S541–S542. https://doi.org/10.1093/ecco-jcc/jjx180.968

Chicago

Shin Maeda, A. Takase, K. Hirasawa, Yu Hashimoto, Y. Inayama, Masafumi Nishio, T Ogashiwa, et al. 2018. “P841 A Novel Candidate Pathway for Development of in Patients Atypical Serrated Lesions with KRAS Mutation in Ulcerative Colitis.” Journal of Crohn’s and Colitis 12 (January): S541–42. doi:10.1093/ecco-jcc/jjx180.968.